vimarsana.com

Page 53 - Dexcom Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Analyzing DarioHealth (NASDAQ:DRIO) and Tandem Diabetes Care (NASDAQ:TNDM)

DarioHealth (NASDAQ:DRIO – Get Free Report) and Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, risk, institutional ownership and dividends. Analyst Ratings This is a summary of […]

DexCom (NASDAQ:DXCM) Price Target Raised to $151 00 at Raymond James

DexCom (NASDAQ:DXCM – Get Free Report) had its price objective upped by equities researchers at Raymond James from $147.00 to $151.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage presently has a “strong-buy” rating on the medical device company’s stock. Raymond James’ price objective indicates a potential upside […]

Dexcom Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call for February

Dexcom Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call for February 8, 2024 at 4:30 p m Eastern Time -January 23, 2024 at 08:33 am EST

DexCom, Inc. today announced that it plans to release its fourth quarter and fiscal year 2023 financial results after market close on Thursday, February 8, 2024. Management will hold a conference.

Raymond James Boosts DexCom (NASDAQ:DXCM) Price Target to $151 00

DexCom (NASDAQ:DXCM – Get Free Report) had its price objective lifted by equities research analysts at Raymond James from $147.00 to $151.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage currently has a “strong-buy” rating on the medical device company’s stock. Raymond James’ price objective indicates a potential […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.